3 results match your criteria: "Centre d'investigation clinique Inserm 1435[Affiliation]"
[Evaluation of professional practices concerning proton pump inhibitors in general medicine].
Therapie
November 2023
Centre d'investigation clinique Inserm 1435, CHU de Limoges, 87042 Limoges, France.
Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Cell Rep Med
June 2021
Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, 35033 Rennes, France.
Article Synopsis
- Acute respiratory distress syndrome (ARDS) is a common complication in severe COVID-19 cases that often leads to ICU admission.
- Researchers studied three groups of patients to compare the immune responses associated with COVID-19 ARDS and found a unique immune cell signature in those patients.
- This specific immune profile could lead to personalized treatment approaches for COVID-19-related ARDS, improving overall patient care in the ICU.
Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact.
Intensive Care Med
May 2016
Service de Réanimation, Pôle Thorax-Maladies Cardiovasculaires-Abdomen-Métabolisme, Hôpital Ambroise Paré, Assistance Publique - Hôpitaux de Paris, 92104, Boulogne-Billancourt, France.
Rationale: Increased right ventricle (RV) afterload during acute respiratory distress syndrome (ARDS) may induce acute cor pulmonale (ACP).
Objectives: To determine the prevalence and prognosis of ACP and build a clinical risk score for the early detection of ACP.
Methods: This was a prospective study in which 752 patients with moderate-to-severe ARDS receiving protective ventilation were assessed using transesophageal echocardiography in 11 intensive care units.